0001209191-23-047246.txt : 20230824
0001209191-23-047246.hdr.sgml : 20230824
20230824184929
ACCESSION NUMBER: 0001209191-23-047246
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220729
FILED AS OF DATE: 20230824
DATE AS OF CHANGE: 20230824
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dupont Jakob
CENTRAL INDEX KEY: 0001553335
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39488
FILM NUMBER: 231203370
MAIL ADDRESS:
STREET 1: C/O ONCOMED PHARMACEUTICALS, INC.
STREET 2: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apexigen, Inc.
CENTRAL INDEX KEY: 0001814140
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851260244
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 INDUSTRIAL ROAD, SUITE C
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650.931.6236
MAIL ADDRESS:
STREET 1: 900 INDUSTRIAL ROAD, SUITE C
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
FORMER COMPANY:
FORMER CONFORMED NAME: Brookline Capital Acquisition Corp.
DATE OF NAME CHANGE: 20200603
3/A
1
doc3a.xml
FORM 3/A SUBMISSION
X0206
3/A
2022-07-29
2022-08-08
0
0001814140
Apexigen, Inc.
APGN
0001553335
Dupont Jakob
C/O APEXIGEN, INC.
75 SHOREWAY ROAD, SUITE C
SAN CARLOS
CA
94070
1
0
0
0
Stock Option (right to buy)
4.49
2031-02-12
Common Stock
20489
D
Prior to the date on which the reporting person became subject to Section 16, he was granted an option to purchase 20,489 shares of common stock which vest upon the satisfaction of certain performance metrics. The first threshold was met resulting in the vesting of 5,122 shares. The remaining shares vest upon the achievement of certain additional performance metrics or upon a change in control.
This amendment on Form 3 is filed to report an option that was inadvertently omitted from the Form 3 filed on August 8, 2022.
/s/ Francis Sarena, by power of attorney
2023-08-24